In conclusion, based on the limited amount of data currently available, we propose that emerging evidence supports that Tau function is crucial for normal synaptic physiology and it may be dysregulated in AD potentially through interaction with genetic risk factors in an Aβ-dependent or Aβ-independent manner. The gene discussed is MAPT; the disease is Alzheimer disease.